Adding value to laboratory medicine: a professional responsibility

Author:

Beastall Graham H.12

Affiliation:

1. President, International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Office, Via Carlo Farini 81, 20159 , Milan , Italy

2. University of Glasgow , Glasgow , United Kingdom

Abstract

Abstract Laboratory medicine is a medical specialty at the centre of healthcare. When used optimally laboratory medicine generates knowledge that can facilitate patient safety, improve patient outcomes, shorten patient journeys and lead to more cost-effective healthcare. Optimal use of laboratory medicine relies on dynamic and authoritative leadership outside as well as inside the laboratory. The first responsibility of the head of a clinical laboratory is to ensure the provision of a high quality service across a wide range of parameters culminating in laboratory accreditation against an international standard, such as ISO 15189. From that essential baseline the leadership of laboratory medicine at local, national and international level needs to ‘add value’ to ensure the optimal delivery, use, development and evaluation of the services provided for individuals and for groups of patients. A convenient tool to illustrate added value is use of the mnemonic ‘SCIENCE’. This tool allows added value to be considered in seven domains: standardisation and harmonisation; clinical effectiveness; innovation; evidence-based practice; novel applications; cost-effectiveness; and education of others. The assessment of added value in laboratory medicine may be considered against a framework that comprises three dimensions: operational efficiency; patient management; and patient behaviours. The profession and the patient will benefit from sharing examples of adding value to laboratory medicine.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Reference39 articles.

1. Report of the review of NHS pathology services in England. An independent review for the Department of Health. London: Department of Health, 2006:6.

2. Hallworth MJ. The ‘70% claim’: what is the evidence base? Ann Clin Biochem 2011;48:487–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000297489700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3

3. The value of laboratory medicine to health care. Chapter 1. The Lewin Group: laboratory medicine – a national status report, May 2008: 19–65. Available from: http://www.ascls-sd.org/sitebuildercontent/sitebuilderfiles/laboratory_medicine_-_a_national_status_reportmay08.pdf. Accessed 16 September, 2012.

4. MaRS Discovery District. Life sciences: molecular diagnostics. New tools for evidence-based medicine. September 2009. Available from: http://www.marsdd.com/wp-content/uploads/2011/02/MaRSReport-Molecular-Diagnostics.pdf. Accessed 16 September, 2012.

5. Billings P. Three barriers to innovative diagnostics. Nature Biotechnol 2006;24:917–8.10.1038/nbt0806-917

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3